Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[h]chromeno[2,3-d]pyrimidine on Human Breast Cancer Cell Line MCF-7
Molecules · 2024
DOI: 10.3390/molecules29194697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Zainab M Khoder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan, Cairo 11795, Egypt. Hauptthemen laut MEDLINE: Apoptosis, Molecular Docking Simulation, Cell Cycle Checkpoints, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taif University, Saudi Arabia.
Abstract (Originalsprache)
Breast cancer is the predominant form of cancer among women and ranks as the second most prevalent cancer globally, affecting both developed and less developed countries. Presently, accessible cancer treatment methods either employ recently created, secure, and efficient chemotherapeutic medications or directly target innovative pathways that cause apoptosis. One of the indirect strategies for treating this fatal illness has mostly depended on its essential role in cell cycle arrest and apoptosis induction, as well as the antagonistic interaction between the Bcl-2 and Mcl-1 proteins, in order to avert major health repercussions. We reported that newly synthesized fused chromenopyrimidines (3a and 4a) showed potential cell cycle arrest and dual Bcl-2 and Mcl-1 inhibitory characteristics. Bcl-2 and Mcl-1 were the targets of a molecular docking procedure. The previous docking results are in line with the biological data and suggest that 3a may have promising anti-cancer activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan, Cairo 11795, Egypt.
- Department of Chemistry, The State University of New York at Buffalo, New York, NY 14260, USA.
- Pharmacy Department, Al-zahrawi University College, Carbala 56001, Iraq.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.
- Medical Biochemistry Department, National Research Centre, Doki, P.O. Box 12622 Cairo, Egypt.
ORCID-Profile: Zainab M Khoder, Amal F Gharib, Omnia Aly, Marwa Abd El-Fattah Khodair, Samar S Fatahala
Förderung
- Taif University, Saudi Arabia
Zitieren
APA
Khoder, Z. M., Mohamed, M. S., Awad, S. M., Gharib, A. F., Aly, O., Khodair, M. A. E., Fatahala, S. S., & El-Hameed, R. H. A. (2024). Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[h]chromeno[2,3-d]pyrimidine on Human Breast Cancer Cell Line MCF-7. Molecules. https://doi.org/10.3390/molecules29194697
Vancouver
Khoder ZM, Mohamed MS, Awad SM, Gharib AF, Aly O, Khodair MAE, et al. Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[h]chromeno[2,3-d]pyrimidine on Human Breast Cancer Cell Line MCF-7. Molecules. 2024. doi:10.3390/molecules29194697
BibTeX
@article{Khoder2024,
author = {Khoder, Zainab M and Mohamed, Mosaad S and Awad, Samir M and Gharib, Amal F and Aly, Omnia and Khodair, Marwa Abd El-Fattah and Fatahala, Samar S and El-Hameed, Rania H Abd},
title = {Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[h]chromeno[2,3-d]pyrimidine on Human Breast Cancer Cell Line MCF-7},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29194697}
}
EUVIMED